Biopharma SHAKTI scheme – Artifex.News https://artifex.news Stay Connected. Stay Informed. Fri, 06 Feb 2026 12:37:00 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://artifex.news/wp-content/uploads/2026/05/cropped-cropped-app-logo-32x32.png Biopharma SHAKTI scheme – Artifex.News https://artifex.news 32 32 More, and less: On Budget 2026 and health-care spending https://artifex.news/article70596060-ece/ Fri, 06 Feb 2026 12:37:00 +0000 https://artifex.news/article70596060-ece/ Read More “More, and less: On Budget 2026 and health-care spending” »

]]>

While this year’s health-care allocations are aggressive in certain key sectors, it has failed expectations that Budget 2026 would be a milestone for increased health-care spending as a percentage of GDP. The total allocation this year is over ₹1.05 lakh crore, marking an increase of about 10% over the previous year’s revised estimates. However, experts have pointed out that the 2026 health budget is approximately 1.9% of the total government expenditure, and about 0.26% of GDP. Finance Minister Nirmala Sitharaman fronted the Biopharma SHAKTI scheme, among the projects with the single highest budgetary allocations this year. This ₹10,000 crore government initiative will transform India into a manufacturing hub for biologics and biosimilars over the next five years, she said. A pan-country clinical state-of-the-art trial infrastructure will also be created, through a network of 1,000 accredited clinical trial sites. No doubt, this will take care of an angle that has long been languishing in India — research and development. Additionally, the government will set up three new National Institutes of Pharmaceutical Education and Research (NIPER) and modernise seven existing units, besides establishing a second NIMHANS campus in north India and two upgraded national mental health institutes. The government has set itself a target of training one lakh allied health professionals over the next five years, while another 1.5 lakh care workers will also be trained to take care of the health needs of the elderly; this is appreciable at a time when India is well on its way towards becoming a grey nation, with fertility levels falling. In the area of making care affordable, the government has exempted 17 cancer medicines and several treatments for rare diseases from customs and import duties, while also reducing the tax collected at source on medical and educational remittances from 5% to 2%. For patients suffering from these conditions, and their families, this will no doubt lead to better affordability for treatments.

Primarily under fire was the Union government’s stodgy refusal to increase the allocation for health care to reach 2.5% of GDP by 2025, as committed in the National Health Policy of 2017. Public health activists have lambasted the drop in funding for the National Health Mission, despite the fact that funds have been consistently well utilised here. While fiscal devolution has enabled States to invest more heavily in the health sector, there are concerns, however, that the Centre steadily reducing its share will result in patchy outcomes, not even improvements, in the health-care sector of the country.



Source link

]]>
Credible and creditable: On Union Budget 2026-27 https://artifex.news/article70578790-ece/ Mon, 02 Feb 2026 06:18:00 +0000 https://artifex.news/article70578790-ece/ Read More “Credible and creditable: On Union Budget 2026-27” »

]]>

Where Budget 2025 was largely dominated by the income-tax rate and slab relaxations, Budget 2026 has done away with Big Bang measures. Instead, its scattershot approach, through various sectoral and issue-based measures, when taken together, is aimed at propelling India’s growth over the medium term. Given the level of geoeconomic and geopolitical uncertainties that the Indian economy faces, this diffused approach is likely a more effective policy than targeted Big Bang announcements would be. This is not the time for further disruption. Budget 2026 contains announcements for the manufacturing sector, various services sectors, as well as particular provisions to help labour-intensive sectors such as textiles and leather. In terms of manufacturing, the Budget includes measures covering seven well thought-out areas: biopharma, semiconductors, electronics, rare earths, chemicals, capital goods and textiles. Semiconductor and electronics manufacturing are the few sectors that have gained from the government’s existing PLI schemes. The India Semiconductor Mission 2.0 and the increased allocation under the Electronics Component Manufacturing Scheme are appropriate follow-ups to this. These are sectors where India needs to become globally competitive. The Biopharma SHAKTI scheme is aimed at making India a global biopharma manufacturing hub with an allocation of ₹10,000 crore over the next five years. Pharmaceuticals, already a sector that India does well in, are exempt from the U.S.’s 50% tariffs. It is also important to support those sectors that are currently hit by those same tariffs. The National Export Promotion Mission announced in the last Budget was implemented only by December 2025, nine months into the financial year. The Centre should ensure that this Budget’s integrated programme for the textiles sector does not face similar delays. Also, the various measures aimed at creating ‘Champion MSMEs’, providing them equity, liquidity, and professional support, must be implemented quickly. MSMEs account for 48.6% of India’s exports, and the EU FTA, even if it is implemented soon, will not kick in quick enough to offset the ongoing pain caused by the U.S. tariffs. The services sector, too, stands to benefit from Budget 2026. The high-powered ‘education to employment and enterprise’ standing committee, announced by the Finance Minister, should get off the ground soon. The focus on health care and medical tourism, where India is already developing strengths, is a good start. In keeping with the Budget’s multipronged approach, the Centre has sought to cater to the election-bound States this year through several smaller announcements — such as dedicated rare earth corridors to benefit Odisha, Kerala, Andhra Pradesh and Tamil Nadu, a Coconut Promotion Scheme for Kerala, an integrated East Coast Industrial Corridor for West Bengal, and the first of the new national waterways to begin in Odisha — rather than through the consolidated packages of the past.

As for the Centre’s finances, Budget 2026 offers a mix of expenditure enthusiasm and revenue sobriety. The capital expenditure push, especially with regard to infrastructure creation, has continued, perhaps in reaction to the realisation that current conditions do not encourage private investment. Overall, capital expenditure is set to grow to ₹12.2 lakh crore in 2026-27, amounting to 4.4% of GDP, the highest in at least the last 10 years. This includes the announcement of dedicated freight corridors and training institutes for the manpower needed. These rail corridors are also to be supplemented by a Coastal Cargo Promotion Scheme to incentivise increasing the share of inland waterways and coastal shipping. It is noteworthy that the Centre has revised downwards its capital expenditure for 2025-26 to ₹10.9 lakh crore from the ₹11.2 lakh crore initially budgeted. It remains to be seen if this year’s target will be met, but even coming close will provide a substantial fillip to the economy. On the revenue front, the Centre did not announce any major tax cuts for individuals or corporations. In 2019 and 2025, respectively, corporations and individuals received substantial tax relief. To announce more would have put undue stress on central finances at a time when its expenditure commitments — known and anticipated — are substantial. However, while direct taxes have largely received procedural improvements, the Budget has included a slew of indirect tax relaxations for the promotion of marine, leather and textile products exports, and speeding up India’s energy transition. The tax revenue projections are largely sober. Corporate tax revenue is projected to grow nearly 14% over the Budget estimates of 2025-26. This is broadly in line with the revised estimates for 2025-26 coming in 12.4% higher than the actuals of the previous year. Income-tax revenue has been budgeted to grow 1.9% over the BE of 2025-26 — an expected outcome following last Budget’s substantial rate relaxations. Gross GST revenue has been projected to contract 13.5% in 2026-27, a reflection of the September 2025 rate rationalisation and the end of the Compensation Cess. Taken together, the Centre’s fiscal deficit has been projected at 4.3% of GDP in 2026-27, down from 4.4% estimated for 2025-26. While the Centre’s fiscal consolidation path since the COVID-19 pandemic has been admirable, continued aggression in reducing the deficit deserves some questioning. Even the Economic Survey argued for some fiscal flexibility for the Centre given the geoeconomic and geopolitical conditions. Overall, Budget 2026 may disappoint those looking for massive tax relief or subsidies, but is nevertheless a credible and creditable effort.



Source link

]]>